Post-earnings recap
Reported
Thu, Feb 1, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported an EPS of $1.40, slightly missing expectations. The stock reacted negatively, dropping 2.12%, likely reflecting investor disappointment in the earnings performance. Without additional guidance or commentary from management, the outlook remains uncertain.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.40 | N/A | -0.72% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.